FIRST SERVICE (02107) issues a profit warning, expecting a net profit of no more than 28 million yuan for the interim period.
First Service Holdings (02107) announced that the group's net profit for the six months ending June 30, 2026 (the "period") is expected to not exceed RMB 28 million, compared to approximately RMB 39.6 million for the same period in 2025. The profit attributable to the company's equity shareholders for the period is expected to not exceed RMB 21 million, while in the same period of 2025, it was about RMB 28.2 million. This decrease is mainly due to the group's proactive optimization of its project portfolio and an orderly exit from several projects with lower profit margins, resulting in reduced revenue, while operating costs have not proportionally decreased in the short term, leading to a decline in gross profit.
FIRST SERVICE (02107) issued an announcement indicating that the net profit of the Group for the six-month period ending June 30, 2026 (the "Period") is expected to be no more than RMB 28 million, while the net profit for the same period in 2025 was approximately RMB 39.6 million. The profit attributable to equity shareholders of the Company during this Period is expected to be no more than RMB 21 million, whereas the profit attributable to equity shareholders of the Company for the same period in 2025 was about RMB 28.2 million. The decrease is mainly due to the Group's proactive optimization of its project portfolio and the orderly exit from several projects with lower gross margins, resulting in reduced revenue, while operating costs have not decreased proportionally in the short term, leading to a decline in gross profit.
Related Articles

HJ SCIENCE-B (06132) recommends adopting the H-share incentive plan for 2026.

SKB BIO (06990) released its interim results, with shareholders' net profit reaching 388 million yuan, marking a turnaround from loss to profit compared to the same period last year.

BlackRock increased its holdings in INNOVENT BIO (01801) by 139,500 shares at a price of HKD 95.375 per share.
HJ SCIENCE-B (06132) recommends adopting the H-share incentive plan for 2026.

SKB BIO (06990) released its interim results, with shareholders' net profit reaching 388 million yuan, marking a turnaround from loss to profit compared to the same period last year.

BlackRock increased its holdings in INNOVENT BIO (01801) by 139,500 shares at a price of HKD 95.375 per share.

RECOMMEND





